UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Dennis Slamon, MD

Print
Email

Dennis Slamon, MD

UCLA Physician Dennis Slamon, MD specializes in Hematology & Oncology.
Specialty
Hematology & Oncology
Gender
Male
Language Spoken
English
Hospital Affiliation
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
State License Number
G39056
Contact
(310) 206-6909 Information and referral
(888) ONC-UCLA Information and appointments
(310) 825-5193 Administrative office
Voted Best Doctor
Voted Super Doctor
PRACTICE LOCATION

Westwood
UCLA Oncology Center
200 UCLA Medical Plaza Suite 120
Los Angeles, CA 90095

Santa Monica
2020 Santa Monica Blvd, Suite 600
Santa Monica, CA 90404

MEDICAL BOARD CERTIFICATION
Medical Oncology, American Board of Internal Medicine, 1981
Internal Medicine, American Board of Internal Medicine, 1978
EDUCATION
Fellowship
Hematology-Oncology, UCLA School of Medicine, 1979 - 1982
Residency
Internal Medicine, University of Chicago Hospitals, 1976 - 1979
Internship
Internal Medicine, University of Chicago Hospitals, 1975 - 1976
Degree
MD, University of Chicago Pritzker School of Medicine, 1975
CLINICAL INTEREST
Breast, Ovarian Cancer
AFFILIATION
Department Affiliation
Chief, Hematology / Oncology
Director, Breast Cancer Program
Provider, Dumont-UCLA Liver Cancer Center
MORE INFORMATION
Additional Information

Dennis J. Slamon, M.D., Ph.D., serves as director of Clinical/Translational Research, and as director of the Revlon/UCLA Women's Cancer Research Program at JCCC. He is a professor of medicine, chief of the Division of Hematology/Oncology and executive vice chair for research for UCLA's Department of Medicine. Slamon also serves as director of the medical advisory board for the National Colorectal Cancer Research Alliance, a fund-raising organization that promotes advances in colorectal cancer.

For 12 years, Dr. Slamon and his colleagues conducted the laboratory and clinical research that led to the development of the new breast cancer drug Herceptin, which targets a specific genetic alteration found in about 25 percent of breast cancer patients. To acknowledge Slamon's accomplishments, President Clinton appointed Slamon to the three-member President's Cancer Panel in June 2000.

A 1975 honors graduate of the University of Chicago's Pritzker School of Medicine, Slamon earned his Ph.D. in cell biology that same year. He completed his internship and residency at the University of Chicago Hospitals and Clinics, becoming chief resident in 1978. One year later, he became a fellow in the Division of Hematology/Oncology at UCLA.

Awards & Recognition

Dr. Slamon has won nearly a dozen national research awards honoring his scientific endeavors.

In 2000, Slamon was awarded the Translational Medicine Award by the USCD-Salk Institute as well as the Bristol-Myers Squibb Oncology Millennium Award for significant achievement and leadership in breast cancer research.
In 2001, Slamon was awarded the Wadsworth Center's Brown-Hazen Award for Excellence in the Basic Sciences, and in 2002, he received the Jeffrey A. Gottlieb Memorial Award from the M.D. Anderson Cancer Center in Texas.
In 2003, Slamon received the Dorothy P. Landon-AACR Prize for Translational Cancer Research, an international award given by the Kirk A. and Dorothy P. Landon Foundation and the American Association for Cancer Research.
And in 2004, the American Cancer Society presented Slamon with the Medal of Honor, the top award bestowed by the organization.

Dr. Slamon received the Fifth Aultman Cancer Center Award from Kent State University and the David A. Karnofsky Memorial Award and Lecture at the American Society of Clinical Oncology honoring his work in the development of Herceptin, a molecularly targeted breast cancer therapy. He also received the Warren Alpert Foundation Scientific Prize and the 2007 Gairdner Foundation International Award for his work in the development of Herceptin.

Publications

UCLA Health System Publications

Physician Update : Summer 2007 - Oncology
Clinical Update: March 2007 - Surgical Oncology
Vital Signs Fall 2005: Breast Cancer Research Explores Promising Treatments

Link to my PubMed publications.

Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Dennis Slamon, click here to update your profile.